What is the recommended acute and long‑term management for Prinzmetal (variant) angina?

Management of Prinzmetal (Variant) Angina

For acute episodes of Prinzmetal angina, administer sublingual or intravenous nitroglycerin immediately, which is exquisitely effective in relieving coronary spasm; for long-term management, initiate high-dose calcium channel blockers (verapamil 240-480 mg/day, diltiazem 180-360 mg/day, or nifedipine 60-120 mg/day) as first-line therapy, adding long-acting nitrates if symptoms persist, and avoid beta-blockers as they have theoretical adverse potential. 1, 2, 1

Acute Management

When a patient presents with active chest pain and ST-segment elevation:

• Immediate nitroglycerin administration (sublingual or IV) is the cornerstone of acute treatment, as it rapidly reverses coronary spasm 1
• If spasm occurs during coronary angiography, inject 0.3 mg nitroglycerin directly into the affected coronary artery 1
• Symptoms and ST-segment elevation typically resolve within minutes with nitroglycerin 3

Long-Term Medical Management

First-Line Therapy: High-Dose Calcium Channel Blockers

Start with a single calcium channel blocker at high doses 4:

• Verapamil: 240-480 mg/day
• Diltiazem: 180-360 mg/day (up to 260 mg/day per some guidelines 4)
• Nifedipine: 60-120 mg/day

The evidence shows calcium channel blockers are more effective than nitrates in preventing attacks of resting angina, though they achieve complete symptom resolution in only 38% of patients as monotherapy 4.

Escalation Strategy for Inadequate Response

If high-dose monotherapy fails to eliminate episodes completely:

1. Add long-acting nitrates to the calcium channel blocker 1, 2, 1
2. Consider combination of two calcium channel blockers from different classes (a dihydropyridine with verapamil or diltiazem) plus nitrates for very active disease 1
3. Alpha-receptor blockers may provide benefit in refractory cases not responding to calcium channel blockers and nitrates 1, 2, 1
4. Nicorandil (a potassium channel activator) may be useful in occasional patients with refractory vasospastic angina 4

Critical Medication Considerations

Beta-blockers have theoretical adverse potential and controversial clinical effects in vasospastic angina 1. They should generally be avoided as they may worsen coronary spasm 5.

Aspirin in large doses is contraindicated in pure vasospastic angina 5, though the role of aspirin remains controversial 4.

Essential Lifestyle Modifications

Smoking cessation is mandatory - this is emphasized across all guidelines as essential, not optional 1, 2, 1, 4. Smoking is a major precipitating factor for coronary spasm.

Diagnostic Confirmation

The diagnosis requires documentation of transient ST-segment elevation during chest pain that resolves spontaneously or with nitroglycerin 3, 1, 3. Key diagnostic approaches include:

• Continuous 12-lead ECG monitoring (in-hospital or ambulatory) during multiple pain episodes 1, 6
• Coronary angiography to assess for underlying coronary artery disease and guide prognosis 1, 2, 1
• Provocative testing (acetylcholine, ergonovine, or methacholine) during angiography when diagnosis is suspected but not documented, only if no high-grade obstructive lesions are present 1, 2, 6

Prognosis and Treatment Duration

Prognosis is excellent in patients with normal or near-normal coronary arteries (89-97% five-year survival), but worse with coexisting obstructive coronary disease (80% five-year survival with multivessel disease) 1. Long-term calcium channel blocker use improves survival without myocardial infarction 7.

Spontaneous remission occurs in approximately 50% of patients after at least 1 year of medical treatment, making it acceptable to taper and discontinue therapy 6-12 months after angina disappears 4.

Special Considerations

• Patients with vasospasm superimposed on significant coronary artery disease require both vasodilator therapy AND guideline-directed medical therapy for obstructive disease (antiplatelet agents, statins, ACE inhibitors) 4, 2
• Occasional patients may require pacemaker implantation for transient AV block or defibrillator for prevention of sudden death from ischemia-induced ventricular fibrillation 1
• Cardiac denervation has been used in refractory cases with marginal benefit 1

Common Pitfalls to Avoid

• Do not use beta-blockers as they may worsen vasospasm
• Do not use large doses of aspirin in pure vasospastic angina
• Do not perform provocative testing in patients with high-grade obstructive lesions 2
• Do not mistake early acute MI for variant angina - both can present with ST-elevation, but MI progresses rather than resolves cyclically 2, 1
• Do not undertitrate calcium channel blockers - high doses are required for efficacy